Adam P. Mecca

Adam P. Mecca

Auto-generated profile, based on publicly available information

Adam P. Mecca

Yale School of Medicine New Haven Connecticut USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 May 2020 in Alzheimer's & Dementia
Verified
Journal Article
Open access
PDF file
AMAdam P. Mecca
Adam P. Mecca
MCMing‐Kai Chen
Ming‐Kai Chen
RORyan S. O'DEll
Ryan S. O'DEll
MNMika Naganawa
Mika Naganawa
TTTakuya Toyonaga
Takuya Toyonaga
CDChristopher H. van Dyck
Christopher H. van Dyck
Introduction: Synaptic loss is a robust and consistent pathology in Alzheimer's disease (AD) and the major structural correlate of cognitive impairment. Positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) has emerged as a promising biomarker of synaptic density.Methods: We measured SV2A binding in 34 participants with early AD and 19 cognitively normal (CN) participants using [11C]UCB‐J PET and a cerebellar reference region for calculation of the distribution volume ratio.Results: We observed widespread reductions of SV2A binding in medial temporal and neocortical brain regions in early AD compared to CN participants. These reductions were largely maintained after correction for volume loss and were more extensive than decreases in gray matter volume.Conclusion: We were able to measure widespread synaptic loss due to AD using [11C]UCB‐J PET. Future studies will continue to evaluate the utility of SV2A PET for tracking AD progression and for monitoring potential therapies.

17 February 2022 in Alzheimer's & Dementia
Verified
Journal Article
Open access
PDF file
AMAdam P. Mecca
Adam P. Mecca
RORyan S. O'DEll
Ryan S. O'DEll
ESEmily S. Sharp
Emily S. Sharp
EBEmmie R. Banks
Emmie R. Banks
HBHugh H. Bartlett
Hugh H. Bartlett
CDChristopher H. van Dyck
Christopher H. van Dyck
Introduction: For 30 years synapse loss has been referred to as the major pathological correlate of cognitive impairment in Alzheimer's disease (AD). However, this statement is based on remarkably few patients studied by autopsy or biopsy. With the recent advent of synaptic vesicle glycoprotein 2A (SV2A) positron emission tomography (PET) imaging, we have begun to evaluate the consequences of synaptic alterations in vivo.Methods: We examined the relationship between synaptic density measured by [11C]UCB‐J PET and neuropsychological test performance in 45 participants with early AD.Results: Global synaptic density showed a significant positive association with global cognition and performance on five individual cognitive domains in participants with early AD. Synaptic density was a stronger predictor of cognitive performance than gray matter volume.Conclusion: These results confirm neuropathologic studies demonstrating a significant association between synaptic density and cognitive performance, and suggest that this correlation extends to the early stages of AD.

20 November 2021 in Neurobiology of Aging
Verified
Journal Article
Open access
AMAdam P. Mecca
Adam P. Mecca
MCMing-Kai Chen
Ming-Kai Chen
RORyan S. O'DEll
Ryan S. O'DEll
MNMika Naganawa
Mika Naganawa
TTTakuya Toyonaga
Takuya Toyonaga
CDChristopher H. van Dyck
Christopher H. van Dyck
Sites of early neuropathologic change provide important clues regarding the initial clinical features of Alzheimer’s disease (AD). We have shown significant reductions in hippocampal synaptic density in participants with AD, consistent with the early degeneration of entorhinal cortical (ERC) cells that project to hippocampus via the perforant path. In this study, [11C]UCB-J binding to synaptic vesicle glycoprotein 2A (SV2A) and [18F]flortaucipir binding to tau were measured via PET in 10 participants with AD (5 mild cognitive impairment, 5 mild dementia) and 10 cognitively normal participants. In the overall sample, ERC tau was inversely associated with hippocampal synaptic density (r=−0.59, P=0.009). After correction for partial volume effects, the association of ERC tau with hippocampal synaptic density was stronger in the overall sample (r=−0.61, P=0.007) and in the AD group where the effect size was large, but not statistically significant (r=−0.58, P=0.06). This inverse association of ERC tau and hippocampal synaptic density may reflect synaptic failure due to tau pathology in ERC neurons projecting to the hippocampus.

18 January 2020 in Alzheimer's Research & Therapy
Verified
Journal Article
Open access
PDF file
AMAdam P. Mecca
Adam P. Mecca
JMJulia W. McDonald
Julia W. McDonald
HMHannah R. Michalak
Hannah R. Michalak
TGTyler A. Godek
Tyler A. Godek
JHJoanna E. Harris
Joanna E. Harris
CDChristopher H. van Dyck
Christopher H. van Dyck
Background: Metabotropic glutamate subtype 5 receptors (mGluR5) modulate synaptic transmission and may constitute an important therapeutic target in Alzheimer’s disease (AD) by mediating the synaptotoxic action of amyloid-β oligomers. We utilized the positron emission tomography (PET) radioligand [18F]FPEB to investigate mGluR5 binding in early AD. Methods: Sixteen individuals with amnestic mild cognitive impairment (MCI) due to AD or mild AD dementia who were positive for brain amyloid were compared to 15 cognitively normal (CN) participants who were negative for brain amyloid. Diagnostic groups were well balanced for age, sex, and education. Dynamic PET scans were acquired for 60 min, starting at 60 min after the initial administration of up to 185 MBq of [18F]FPEB using a bolus-plus-constant-infusion method (Kbol = 190 min). Equilibrium modeling with a cerebellum reference region was used to estimate [18F]FPEB binding (BPND) to mGluR5. Analyses were performed with and without corrections for gray matter atrophy and partial volume effects. Results: Linear mixed model analysis demonstrated a significant effect of group (p = 0.011) and the group × region interaction (p = 0.0049) on BPND. Post hoc comparisons revealed a significant reduction (43%) in mGluR5 binding in the hippocampus of AD (BPND = 0.76 ± 0.41) compared to CN (BPND = 1.34 ± 0.58, p = 0.003, unpaired t test) participants, and a nonsignificant trend for a reduction in a composite association cortical region in AD (BPND = 1.57 ± 0.25) compared to CN (BPND = 1.86 ± 0.63, p = 0.093) participants. Exploratory analyses suggested additional mGluR5 reductions in the entorhinal cortex and parahippocampal gyrus in the AD group. In the overall sample, hippocampal mGluR5 binding was associated with episodic memory scores and global function. Conclusions: [18F]FPEB-PET revealed reductions in hippocampal mGluR5 binding in early AD. Quantification of mGluR5 binding in AD may expand our understanding of AD pathogenesis and accelerate the development of novel biomarkers and treatments.

12 October 2020 in Alzheimer's & Dementia
Verified
Journal Article
Closed access
PDF file
AMAdam P. Mecca
Adam P. Mecca
CDChristopher H. van Dyck
Christopher H. van Dyck

11 August 2023 in The American Journal of Geriatric Psychiatry
Verified
Journal Article
Open access
JSJason A. Silva-Rudberg
Jason A. Silva-Rudberg
ESElaheh Salardini
Elaheh Salardini
RORyan S. O'DEll
Ryan S. O'DEll
MCMing-Kai Chen
Ming-Kai Chen
JRJocelyn Ra
Jocelyn Ra
AMAdam P. Mecca
Adam P. Mecca
Multimodal imaging techniques have furthered our understanding of how different aspects of Alzheimer's disease (AD) pathology relate to one another. Diffusion tensor imaging (DTI) measures such as mean diffusivity (MD) may be a surrogate measure of the changes in gray matter structure associated with AD. Positron emission tomography (PET) imaging of synaptic vesicle glycoprotein 2A (SV2A) has been used to quantify synaptic loss, which is the major pathological correlate of cognitive impairment in AD. In this study, we investigated the relationship between gray matter microstructure and synaptic density. DTI was used to measure MD and [11C]UCB-J PET to measure synaptic density in 33 amyloid-positive participants with AD and 17 amyloid-negative cognitively normal (CN) participants aged 50-83. Univariate regression analyses were used to assess the association between synaptic density and MD in both the AD and CN groups. Hippocampal MD was inversely associated with hippocampal synaptic density in participants with AD (r = -0.55, p <0.001, df = 31) but not CN (r = 0.13, p = 0.62, df = 15). Exploratory analyses across other regions known to be affected in AD suggested widespread inverse associations between synaptic density and MD in the AD group. In the setting of AD, an increase in gray matter MD is inversely associated with synaptic density. These co-occurring changes may suggest a link between synaptic loss and gray matter microstructural changes in AD. Imaging studies of gray matter microstructure and synaptic density may allow important insights into AD-related neuropathology.